CP 0 2 0 2 B-chronic_disease
/ 2 3 2 3 I-chronic_disease
CPPS 3 7 3 7 I-chronic_disease
symptoms 8 16 8 16 O
must 17 21 17 21 O
have 22 26 22 26 O
been 27 31 27 31 O
present 32 39 32 39 O
for 40 43 40 43 O
the 44 47 44 47 O
majority 48 56 48 56 O
of 57 59 57 59 O
the 60 63 60 63 O
time 64 68 64 68 O
during 69 75 69 75 O
any 76 79 76 79 O
3 80 81 80 81 B-upper_bound
months 82 88 82 88 I-upper_bound
in 89 91 89 91 O
the 92 95 92 95 O
previous 96 104 96 104 B-upper_bound
6 105 106 105 106 I-upper_bound
months 107 113 107 113 I-upper_bound

Diagnosed 0 9 114 123 O
with 10 14 124 128 O
Category 15 23 129 137 B-chronic_disease
III 24 27 138 141 I-chronic_disease
Chronic 28 35 142 149 I-chronic_disease
Pelvic 36 42 150 156 I-chronic_disease
Pain 43 47 157 161 I-chronic_disease
Syndrome 48 56 162 170 I-chronic_disease

Females 0 7 171 178 B-gender

Male 0 4 179 183 B-gender

Males 0 5 184 189 B-gender

Mast 0 4 190 194 O
cell 5 9 195 199 O
tryptase 10 18 200 208 O
levels 19 25 209 215 O
in 26 28 216 218 O
EPS 29 32 219 222 B-clinical_variable
equal 33 38 223 228 O
to 39 41 229 231 O
or 42 44 232 234 O
below 45 50 235 240 O
a 51 52 241 242 O
control 53 60 243 250 O
threshold 61 70 251 260 O
of 71 73 261 263 O
25ng 74 78 264 268 B-upper_bound
/ 78 79 268 269 I-upper_bound
ml 79 81 269 271 I-upper_bound
based 82 87 272 277 O
on 88 90 278 280 O
healthy 91 98 281 288 O
men 99 102 289 292 B-gender

Patients 0 8 293 301 O
with 9 13 302 306 O
a 14 15 307 308 O
known 16 21 309 314 O
hypersensitivity 22 38 315 331 O
to 39 41 332 334 O
cromolyn 42 50 335 343 B-allergy_name
sodium 51 57 344 350 I-allergy_name
or 58 60 351 353 O
cetirizine 61 71 354 364 B-allergy_name
hydrochloride 72 85 365 378 I-allergy_name

Patients 0 8 379 387 O
with 9 13 388 392 O
impaired 14 22 393 401 B-chronic_disease
renal 23 28 402 407 I-chronic_disease
or 29 31 408 410 O
hepatic 32 39 411 418 B-chronic_disease
function 40 48 419 427 I-chronic_disease

